Stralem & Co. Inc. continued to hold its stake in Agilent Technologies Inc (NYSE:A) during the first quarter, Holdings Channel reports. The firm owned 17,900 shares of the medical research company’s stock at the end of the first quarter. Stralem & Co. Inc.’s holdings in Agilent Technologies were worth $816,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Cullinan Associates Inc. raised its position in Agilent Technologies by 26.9% in the first quarter. Cullinan Associates Inc. now owns 50,450 shares of the medical research company’s stock worth $2,667,000 after buying an additional 10,700 shares during the period. Cribstone Capital Management LLC raised its position in Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock worth $125,000 after buying an additional 54 shares during the period. Fox Run Management L.L.C. raised its position in Agilent Technologies by 111.0% in the first quarter. Fox Run Management L.L.C. now owns 21,947 shares of the medical research company’s stock worth $1,160,000 after buying an additional 11,547 shares during the period. Private Trust Co. NA raised its position in Agilent Technologies by 2.1% in the first quarter. Private Trust Co. NA now owns 7,660 shares of the medical research company’s stock worth $404,000 after buying an additional 161 shares during the period. Finally, Capstone Asset Management Co. raised its position in Agilent Technologies by 7.4% in the first quarter. Capstone Asset Management Co. now owns 43,126 shares of the medical research company’s stock worth $2,280,000 after buying an additional 2,990 shares during the period.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Shares of Agilent Technologies Inc (NYSE:A) traded down 0.80% during midday trading on Tuesday, reaching $53.03. The company’s stock had a trading volume of 1,241,064 shares. Agilent Technologies Inc has a one year low of $40.26 and a one year high of $54.82. The firm has a market cap of $17.09 billion, a price-to-earnings ratio of 34.02 and a beta of 1.19. The stock’s 50 day moving average price is $52.59 and its 200 day moving average price is $48.26.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, February 14th. The medical research company reported $0.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.04. Agilent Technologies had a return on equity of 15.49% and a net margin of 10.99%. The firm earned $1.07 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the business earned $0.46 EPS. Agilent Technologies’s revenue for the quarter was up 3.8% compared to the same quarter last year. Analysts predict that Agilent Technologies Inc will post $2.15 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 26th. Investors of record on Tuesday, April 4th will be paid a $0.132 dividend. The ex-dividend date of this dividend is Friday, March 31st. This represents a $0.53 annualized dividend and a dividend yield of 1.00%. Agilent Technologies’s dividend payout ratio is presently 37.59%.

ILLEGAL ACTIVITY WARNING: “Stralem & Co. Inc. Has $816,000 Position in Agilent Technologies Inc (A)” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at http://www.dailypolitical.com/2017/04/18/stralem-co-inc-has-816000-position-in-agilent-technologies-inc-a.html.

A has been the subject of a number of research reports. Deutsche Bank AG reissued a “buy” rating and set a $58.00 price target (up from $56.00) on shares of Agilent Technologies in a research note on Sunday, April 2nd. Jefferies Group LLC reissued a “buy” rating and set a $59.00 price target on shares of Agilent Technologies in a research note on Friday, March 17th. Morgan Stanley raised Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $62.00 price target for the company in a research note on Wednesday, March 15th. Zacks Investment Research raised Agilent Technologies from a “sell” rating to a “hold” rating in a research note on Friday, February 17th. Finally, Janney Montgomery Scott increased their price target on Agilent Technologies from $55.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, February 13th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $53.89.

In related news, insider Patrick Kaltenbach sold 2,000 shares of Agilent Technologies stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $52.90, for a total value of $105,800.00. Following the sale, the insider now directly owns 42,132 shares in the company, valued at approximately $2,228,782.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Didier Hirsch sold 22,256 shares of Agilent Technologies stock in a transaction dated Wednesday, February 1st. The stock was sold at an average price of $49.50, for a total value of $1,101,672.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 84,644 shares of company stock valued at $4,306,465.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

5 Day Chart for NYSE:A

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.